Genetics brings automated genotyping lab is fully licensed for testing in all 50 US states and is capable of processing over one m samples per year.
Orig3n acquires Interleukin
Genetics' CLIA-Certified Genetics Laboratory in Waltham, Massachusetts.
Blood was centrifuged for ten minutes at 13000 rpm and plasma was separated for biochemical analysis of cytokines (IL- 6 and IL-18) through enzyme-linked immunoabsorbent assay ELISA by using the diagnostic kits [MBL for interleukin
-18 and Invitrogen CMC0063 for interleukin
6] following manufacturer's recommendations.
Genetics sold 500,000 pieces of its series B convertible preferred shares to its strategic partner, dental benefits provider Delta Dental Plan of Michigan, which has supported Interleukin
Genetics' steps to advance its periodontal disease susceptibility risk test, PST.
The addition of these novel gene variations to our growing portfolio of SNPs in the key genes that regulate inflammation is a critical achievement for Interleukin
I welcome the opportunity to work with Interleukin
and its strategic partners to provide the marketing leadership necessary to advance personalized care in dentistry through the regular use of the PST([R]) genetic test and personalized medicine overall," said Scott Snyder, Chief Marketing Officer, Interleukin
The acquisition is intended to allow Interleukin
Genetics' technology to become a core component of Orig3n's DNA test business.
Findings by Interleukin
Genetics on the genetics of OA, in collaboration with NYU School of Medicine researchers Dr.
When the researchers inhibited interleukin
4 signaling in white fat, they found that the mice made less beige fat, burned less energy, and could no longer maintain normal body temperature in the cold.
I welcome the opportunity to lead Interleukin
during this exciting time and to work with our new strategic partner, Delta Dental of Michigan, toward our goal of potentially providing more personalized care for the prevention of periodontal disease," said Ken Kornman.
The company's founder, current president and chief scientific officer, Kornman said, "I welcome the opportunity to lead Interleukin
during this exciting time and to work with our new strategic partner, Delta Dental of Michigan, toward our goal of potentially providing more personalised care for the prevention of periodontal disease.